Skip to main content

Advertisement

Log in

Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare the efficacy of proton pump inhibitor (PPI) with H2 receptor antagonist (H2RA) in treatment of upper abdominal symptoms.

Methods

This was a multi-center, open study conducted at 102 hospitals in Japan. Patients with reflux esophagitis received famotidine 10 mg twice daily for 2 weeks, then omeprazole 10 mg once daily for 2 weeks. Thereafter, patients were switched to famotidine 10 mg twice daily for a third 2-weekperiod, provided those with a medical condition agreed to continue the study. Patients evaluated the treatment response to each gastrointestinal symptom using a predefined patient questionnaire and gastrointestinal symptom rating scale (GSRS).

Results

161 patients entered the study, of whom 8 were excluded from all analyses due to lack of participation following entry. Overall symptom improvement rate (n = 130) at week 4, after the 2-week omeprazole treatment, was 75.4% and this was significantly higher than that after the first 2-week famotidine treatment (41.5%) at week 2. In patients (n = 36) who completed 6 weeks of treatment, 2-week omeprazole treatment at week 4 showed a significantly higher overall symptom improvement rate compared with both the first 2-week and third 2-week famotidine treatments.

Conclusions

Omeprazole was superior to famotidine for treatment of upper abdominal symptoms in patients with reflux esophagitis, which suggested that gastric acid might be a cause not only of reflux symptoms, but also of ulcer symptoms and dysmotility symptoms such as epigastric pain and feeling of fullness in reflux esophagitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.

    Article  PubMed  Google Scholar 

  2. Stanghellini V. Three-month prevalence rate of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance (DIGEST). Scand J Gastroenterol. 1999;231:20–8.

    Article  CAS  Google Scholar 

  3. Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Am J Gastroenterol. 1999;94:2845–54.

    Article  PubMed  CAS  Google Scholar 

  4. Thomson ABR, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant upper gastrointestinal findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17:1481–91.

    Article  PubMed  CAS  Google Scholar 

  5. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79.

    Article  PubMed  Google Scholar 

  6. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the information of the Rome III classification. J Gastroenterol. 2006;41:513–23.

    Article  PubMed  Google Scholar 

  7. Talley NJ, Vakil N. Guidelines for management of dyspepsia. Am J Gastroenterol. 2005;100:2324–37.

    Article  PubMed  Google Scholar 

  8. Veldhuyzen van Zanten SJO, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care physicians with dyspepsia: the CADET-HN study. Am J Gastroenterol. 2005;100:1477–88.

    Article  PubMed  CAS  Google Scholar 

  9. Mason I, Millar LJ, Sheikh RR, Evans WMI, Todd PL, Turbitt ML, et al. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther. 1998;12(3):263–71.

    Article  PubMed  CAS  Google Scholar 

  10. Hongo M, Kanatsuka H, Sugawara A, Nagasaki Y, Endo Y, Karahashi K, et al. Primary care in the treatment of functional gastrointestinal symptoms in Japan: prescription preferences and impression of results. Aliment Pharmacol Ther. 2005;21:47–54.

    Article  PubMed  Google Scholar 

  11. Adachi K, Matsumori Y, Fujisawa T, Kamada T, Kusaka M, Ohumi T, et al. Symptom diversity of patients with reflux esophagitis: effect of omeprazole treatment. J Clin Biochem Nutr. 2006;39:46–54.

    Article  CAS  Google Scholar 

  12. Armstrong D, Bennett JR, Blum AL, Dent J, Dombal T, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.

    Article  PubMed  CAS  Google Scholar 

  13. Laheij RJ, De Koning RW, Horrevorts AM, Rongen RJ, Leo Rossum GM, Wittenman EM, et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol. 2004;38:490–5.

    Article  PubMed  Google Scholar 

  14. Chiba N. Treat the patients’ main dyspepsia complaint, not the ROME criteria. Am J Gastroenterol. 2004;99(6):1059–62.

    Article  PubMed  Google Scholar 

  15. van Zanten SV, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled “ENTER” trial. Am J Gastroenterol. 2006;101(9):2096–106.

    Article  PubMed  CAS  Google Scholar 

  16. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45:II37–42.

    PubMed  Google Scholar 

  17. Quigley EMM. Motility, heartburn and dyspepsia. Aliment Pharmacol Ther. 1997;11:41–50.

    Google Scholar 

  18. Penagini R, Hebbard G, Horowitz M, Dent J, Bermingham H, Jones K, et al. Motor function of the proximal stomach and visceral perception in patients with gastroesophageal reflux disease. Gut. 1998;42:251–7.

    Article  PubMed  CAS  Google Scholar 

  19. Tosetti C, Stanghellini V, Tucci A, Poli L, Salvioli B, Biasco G, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci. 2000;45(2):252–7.

    Article  PubMed  CAS  Google Scholar 

  20. Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol. 1998;93(9):1425–31.

    Article  PubMed  CAS  Google Scholar 

  21. Ebara S, Shirasaka D, Aoyama N, Kachi M, Miki I, Morita Y, et al. The relationship between gastric emptying determined by the breath test and H. pylori. Hepatogastroenterology. 2007;54:613–6.

    PubMed  Google Scholar 

  22. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol. 2005;20:1652–60.

    Article  PubMed  Google Scholar 

  23. William DC, Benjamin CYW. American college of gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808–25.

    Article  CAS  Google Scholar 

  24. Samsom M, Verhagen M, Henegouwen G, Smout A. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999;116(3):515–20.

    Article  PubMed  CAS  Google Scholar 

  25. Miwa H, Nakajima K, Yamaguchi K, Fujimoto K, Veldhuyzen VAN, Zanten SJ, et al. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26(2):257–64.

    Article  PubMed  CAS  Google Scholar 

  26. Simren M, Vos R, Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2003;285(2):G309–15.

    PubMed  CAS  Google Scholar 

  27. Lee KJ, Vos R, Janssens J, Tack J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol. 2004;286(2):G278–84.

    Article  PubMed  CAS  Google Scholar 

  28. Coffin B, Chollet R, Flourie B, Lemann M, Franchisseur C, Rambaud JC, et al. Intraluminal modulation of gastric sensitivity to distension: effects of hydrochloric acid and meal. Am J Physiol Gastrointest Liver Physiol. 2001;280(5):G904–9.

    PubMed  CAS  Google Scholar 

  29. Hunt JN, Knox MT. The slowing of gastric emptying by four strong acids and three weak acids. J Physiol. 1972;222(1):187–208.

    PubMed  CAS  Google Scholar 

  30. Hansen AN, Bergheim R, Fagertun H, Lund H, Wiklund I, Moum B. Long-term management of patients with symptoms of gastro-oesophageal reflux disease—a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting. Int J Clin Pract. 2006;60(1):15–22.

    Article  PubMed  CAS  Google Scholar 

  31. Dimenäs E, Glise E, Hallebäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30:1046–52.

    Article  PubMed  Google Scholar 

  32. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

There was no financial support for the study. We would like to thank the following investigators: Iwakiri R, Sakata H, Tsunada S, Ootani H, Sakata Y, Fujise T, Shimoda R, Shiraishi R, Watanabe K, Akiyama T, Saga Medical School; Okada K, Fujiyamato Onsen Hospital; Nakayama S, Kanzaki Clinic; Matsunaga C, Matsunaga Medical Clinic; Matsunaga K, Arima S, Sasebo Kyosai Hospital; Ogata S, Nakahara S, Mannen K, Saga Prefectural Hospital Koseikan; Kikkawa A, Takeo City Hospital; Tsuruta H, Kawazoe H, National Hospital Organization Ureshino Medical Center; Fujioka Y, Yamaguchi K, Fujioka Hospital; Sakata Y, Yuaikai Oda Hospital; Ishibashi S, Koga Pediatric Medical Hospital; Fujisaki J, Fujisaki Clinic; Mori H, Mori Clinic; Mitsuoka S, Mitsuoka Medical Gastrointestinal Clinic; Maeyama H, Maeyama Medical Gastrointestinal Clinic; Danjo A, Oyama T, Saga Social Insurance Hospital; Noda T, Matsumoto Y, Karatsu Red Cross Hospital; Endo H, Kojima M, Saiseikai Karatsu Hospital; Fukuyama K, Karatsu City Hospital Kitahata; Tomonaga M, Tomonaga Clinic; Tanaka T, Tanaka Medical Clinic; Fujimura T, Yamaguchi Hospital; Ono T, Ono Clinic; Tsuchihashi K, Tsuchihashi Clinic; Terada H, Terada Medical Clinic; Inutsuka S, Inutsuka Hospital; Kuwahara A, Omachi Municipal Hospital; Muto Y, Muto Medical Clinic; Moriyama M, Moriyama Medical Gastrointestinal Clinic; Sakata T, Sakata Clinic; Goto S, Amemori S, Taku City Hospital. Sakagami T, Nakajima K, Yamamoto N, Ohshima T, Hyogo College of Medicine; Yamamura M, Kobe Ekisaikai Hospital; Toyoda T, Nomura Kaihin Hospital; Arai E, Nishinomiya Kyoritsu Neurosurgical Hospital; Sawada Y, Takarazuka Municipal Hospital; Hayashi T, Amagasaki Central Hospital; Kishi K, Meiwa Hospital; Yamaji S, Seiwa Hospital; Hara H, Hara Surgery Clinic; Kuroda Y, Kuroda Clinic; Kishimoto Y, Kishimoto Clinic; Kang K, Asahi Clinic; Yamamoto I, Yamamoto Clinic; Akashi H, Akashi Clinic; Takahashi A, Tsukumo Memorial Hospital. Furuta K, Amano Y, Ishihara S, Sato S, Shimane University School of Medicine; Amano K, Masuda Red Cross Hospital; Okuyama T, Kurashiki Medical Center; Matsumori Y, Takatsuki General Hospital; Higashi R, Shibagaki K, Tottori Municipal Hospital; Niigaki M, Shimane Adult Disease Prevention Center; Hamamoto N, Unnan Municipal General Hospital; Mishima I, Masuda Medical Association Hospital; Nishi K, Hyogo Prefectural Awaji Hospital; Inoue H, Miki City Hospital; Yamada H, Maruno T, Shinko Hospital; Kitajima N, Kasai City Hospital; Kawamura A, Yuaikai Ono Municipal Hospital; Kawashima K, Matsue Seikyo General Hospital; Goubaru Y, Goubaru Clinic; Takatori Y, Takatori Clinic; Yuuki T, Matsue City Hospital; Fukuhara K, Abe Clinic; Honda C, Jusei Hospital; Maekawa T, Kanebo Memorial Hospital. Kamata T, Fujita M, Kawasaki Medical School; Sakakibara T, Sakakibara Hospital; Fujimura Y, Kawasaki Hospital; Kawanishi M, Unno M, Kamao T, Kaneda Hospital; Otani K, Otani Hospital; Yoneda M, Yoneda Medical Clinic; Iguchi D, Ochiai Hospital; Watanabe T, Watanabe Gastrointestinal Surgical Hospital; Miyashita K, Mitsubishi Mizushima Hospital; Koga H, Tanaka T, Tarumi K, Satou Memorial Hospital; Sugiu K, Sugiu Clinic; Nishina H, Shimizu K, Takeda M, Ueda Kinen Hospital; Ohumi T, Ohumi Clinic; Sasaki A, JA Onomichi General Hospital; Hamada H, Mitsubishi Mihara Hospital; Tokumo K, Tokumo Gastrointestinal Hospital; Suzuki T, Suzuki Medical Gastrointestinal Clinic; Miyajima N, Kasaoka Daiichi Hospital; Sano T, Sano Medical Clinic; Tanaka R, Kurashiki Heisei Hospital; Koduka K, Koduka Clinic; Kariya K, Mabi Central Hospital; Moritani Y, Moritani Surgical Clinic; Sato K, Sato Gastrointestinal Surgical Hospital; Murakami Y, Murakami Clinic; Nishioka T, Kanbe Clinic.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hiroaki Kusunoki or Ken Haruma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kusunoki, H., Kusaka, M., Kido, S. et al. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. J Gastroenterol 44, 261–270 (2009). https://doi.org/10.1007/s00535-009-0003-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0003-4

Keywords

Navigation